Contact
More
NK and T cells armed with EVE16, a novel synthetic immune receptor, mediate robust anti-tumor responses through dual direct cytotoxicity and ADCC with minimal trogocytosis and exhaustion
Alaa Ali et al. AACR Poster, Abstract #5231. AACR 2024